Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
NCT07099053
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Background: Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other mental abilities. Amyloids are groups of proteins that develop in the brain and increase in number as people age. Researchers want to use imaging scans to track amyloids in people s brains over time. Their goal is to find out if any changes are related to cognitive decline or other medical issues. Objective: To learn how amyloids may affect brain structure and function as people age.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Aging
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 55 to 110 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Institute on Aging (NIA)
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institute of Aging, Clinical Research Unit · Baltimore, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.